184 related articles for article (PubMed ID: 17555529)
1. Coxiella burnetii infection in C57BL/6 mice aged 1 or 14 months.
Leone M; Bechah Y; Meghari S; Lepidi H; Capo C; Raoult D; Mege JL
FEMS Immunol Med Microbiol; 2007 Aug; 50(3):396-400. PubMed ID: 17555529
[TBL] [Abstract][Full Text] [Related]
2. Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection.
Meghari S; Berruyer C; Lepidi H; Galland F; Naquet P; Mege JL
Eur J Immunol; 2007 Jan; 37(1):24-32. PubMed ID: 17163446
[TBL] [Abstract][Full Text] [Related]
3. TLR2 is necessary to inflammatory response in Coxiella burnetii infection.
Meghari S; Honstettre A; Lepidi H; Ryffel B; Raoult D; Mege JL
Ann N Y Acad Sci; 2005 Dec; 1063():161-6. PubMed ID: 16481508
[TBL] [Abstract][Full Text] [Related]
4. Microbicidal property of B1 cell derived mononuclear phagocyte.
Popi AF; Zamboni DS; Mortara RA; Mariano M
Immunobiology; 2009; 214(8):664-73. PubMed ID: 19321225
[TBL] [Abstract][Full Text] [Related]
5. Effect of sex on Coxiella burnetii infection: protective role of 17beta-estradiol.
Leone M; Honstettre A; Lepidi H; Capo C; Bayard F; Raoult D; Mege JL
J Infect Dis; 2004 Jan; 189(2):339-45. PubMed ID: 14722900
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of cyclophosphamide on Coxiella burnetii infection in mice.
Kazár J; Rajcáni J; Schramek S
Acta Virol; 1982 May; 26(3):174-82. PubMed ID: 6127018
[TBL] [Abstract][Full Text] [Related]
7. Comparative virulence of phase I and II Coxiella burnetii in immunodeficient mice.
Andoh M; Russell-Lodrigue KE; Zhang G; Samuel JE
Ann N Y Acad Sci; 2005 Dec; 1063():167-70. PubMed ID: 16481509
[TBL] [Abstract][Full Text] [Related]
8. Role for the CD28 molecule in the control of Coxiella burnetii infection.
Honstettre A; Meghari S; Nunès JA; Lepidi H; Raoult D; Olive D; Mege JL
Infect Immun; 2006 Mar; 74(3):1800-8. PubMed ID: 16495554
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4.
Honstettre A; Ghigo E; Moynault A; Capo C; Toman R; Akira S; Takeuchi O; Lepidi H; Raoult D; Mege JL
J Immunol; 2004 Mar; 172(6):3695-703. PubMed ID: 15004173
[TBL] [Abstract][Full Text] [Related]
10. Role of B cells in host defense against primary Coxiella burnetii infection.
Schoenlaub L; Elliott A; Freches D; Mitchell WJ; Zhang G
Infect Immun; 2015 Dec; 83(12):4826-36. PubMed ID: 26438792
[TBL] [Abstract][Full Text] [Related]
11. Persistent Coxiella burnetii infection in mice overexpressing IL-10: an efficient model for chronic Q fever pathogenesis.
Meghari S; Bechah Y; Capo C; Lepidi H; Raoult D; Murray PJ; Mege JL
PLoS Pathog; 2008 Feb; 4(2):e23. PubMed ID: 18248094
[TBL] [Abstract][Full Text] [Related]
12. Induced production of nitric oxide and sensitivity of alveolar macrophages derived from mice with different sensitivity to Coxiella burnetii.
Yoshiie K; Matayoshi S; Fujimura T; Maeno N; Oda H
Acta Virol; 1999 Oct; 43(5):273-8. PubMed ID: 10757226
[TBL] [Abstract][Full Text] [Related]
13. Dose-response model of Coxiella burnetii (Q fever).
Tamrakar SB; Haluska A; Haas CN; Bartrand TA
Risk Anal; 2011 Jan; 31(1):120-8. PubMed ID: 20723147
[TBL] [Abstract][Full Text] [Related]
14. Intracellular life of Coxiella burnetii in macrophages.
Ghigo E; Pretat L; Desnues B; Capo C; Raoult D; Mege JL
Ann N Y Acad Sci; 2009 May; 1166():55-66. PubMed ID: 19538264
[TBL] [Abstract][Full Text] [Related]
15. Balb/c mouse model and real-time quantitative polymerase chain reaction for evaluation of the immunoprotectivity against Q fever.
Zhang J; Wen B; Chen M; Zhang J; Niu D
Ann N Y Acad Sci; 2005 Dec; 1063():171-5. PubMed ID: 16481510
[TBL] [Abstract][Full Text] [Related]
16. Failure of Q fever phase I corpuscular vaccine to influence the persistence and reactivation of Coxiella burnetii infection in mouse and guinea pig tissues.
Kazár J; Kovácová E
Acta Virol; 1983 Sep; 27(5):418-28. PubMed ID: 6139946
[TBL] [Abstract][Full Text] [Related]
17. Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.
Ochoa-Repáraz J; Sentissi J; Trunkle T; Riccardi C; Pascual DW
Infect Immun; 2007 Dec; 75(12):5845-58. PubMed ID: 17893129
[TBL] [Abstract][Full Text] [Related]
18. Link between impaired maturation of phagosomes and defective Coxiella burnetii killing in patients with chronic Q fever.
Ghigo E; Honstettre A; Capo C; Gorvel JP; Raoult D; Mege JL
J Infect Dis; 2004 Nov; 190(10):1767-72. PubMed ID: 15499532
[TBL] [Abstract][Full Text] [Related]
19. Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages.
Benoit M; Barbarat B; Bernard A; Olive D; Mege JL
Eur J Immunol; 2008 Apr; 38(4):1065-70. PubMed ID: 18350541
[TBL] [Abstract][Full Text] [Related]
20. Coxiella burnetii: host and bacterial responses to infection.
Waag DM
Vaccine; 2007 Oct; 25(42):7288-95. PubMed ID: 17825460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
